Showing results (1641-1650 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|January 10, 2013
Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphomaNils Schoof, Jeremy Franklin, Robert Fürst, et al.
The Oncologist|January 22, 2013
The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeuticsJessica M Scott, Susan Lakoski, John R Mackey, et al.
The Oncologist|January 22, 2013
The end-of-life phase of high-grade glioma patients: dying with dignity?Eefje M Sizoo, Martin J B Taphoorn, Bernard Uitdehaag, et al.
The Oncologist|January 22, 2013
Lower-limb drainage mapping for lymphedema risk reduction after pelvic lymphadenectomy for endometrial cancerAnne-Sophie Bats, Claude Nos, Chérazade Bensaïd, et al.
The Oncologist|December 25, 2012
Critical appraisal of translational research models for suitability in performance assessment of cancer centersAbinaya Rajan, Richard Sullivan, Suzanne Bakker, et al.
The Oncologist|April 6, 2012
Bevacizumab-based therapies in the first-line treatment of metastatic colorectal cancerJohn H Strickler, Herbert I Hurwitz
The Oncologist|March 12, 2013
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III studySandra M Swain, Michael S Ewer, Javier Cortés, et al.
The Oncologist|February 14, 2013
Locoregional interaction of ixabepilone (ixempra) after breast cancer radiationVinita Takiar, Eric A Strom, Donald P Baumann, et al.
The Oncologist|February 14, 2013
Molecular characterization of basal-like and non-basal-like triple-negative breast cancerAleix Prat, Barbara Adamo, Maggie C U Cheang, et al.
The Oncologist|March 5, 2013
Compliance in early-phase cancer clinical trials researchRazelle Kurzrock, David J Stewart
Pageof 571